Hepa-B

BIOLOGICAL2 trials

Sponsors

Norwegian Institute of Public Health, International Centre for Diarrhoeal Disease Research, Bangladesh

Conditions

Hepatitis B InfectionHepatitis E Infection

Phase 2

Non Inferiority Trial of Locally Manufactured 'Hepa-B' Vaccine in Bangladesh.

CompletedNCT03627507

International Centre for Diarrhoeal Disease Research, BangladeshHepatitis B Infection

Start: 2018-07-29End: 2019-06-03Updated: 2022-02-11

Phase 4

Effectiveness Trial to Evaluate Protection of Pregnant Women by Hepatitis E Vaccine in Bangladesh.

CompletedNCT02759991

Norwegian Institute of Public HealthHepatitis E Infection

Start: 2017-10-02End: 2019-09-30Updated: 2024-08-15

Related Papers

Safety and effectiveness of a recombinant hepatitis E vaccine in women of childbearing age in rural Bangladesh: a phase 4, double-blind, cluster-randomised, controlled trial.

2024-08-0114 citations

Receipt of hepatitis E vaccine and fetal loss in rural Bangladesh: further analysis of a double-blind, cluster-randomised, controlled trial.

2024-08-0112 citations

Immunogenicity and safety of a two-dose regimen with hepatitis E virus vaccine in healthy adults in rural Bangladesh: A randomized, double-blind, controlled, phase 2/pilot trial.

2023-01-0221 citations

A non-inferiority trial comparing two recombinant vaccines (Hepa-B vs. Engerix-B) for hepatitis B among adults in Dhaka, Bangladesh

Vaccine2021-09-223 citations

HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh

BMJ Open2020-01-0158 citations